Have a personal or library account? Click to login
Evaluation of the Therapeutic Effects of  Serratiopeptidase in Chicks Cover

Evaluation of the Therapeutic Effects of  Serratiopeptidase in Chicks

Open Access
|Aug 2024

References

  1. Stern, C.D. (2005). The chick: a great model system becomes even greater. Dev Cell. 8(1): 9-17. https://doi.org/10.1016/S1534-5807(04)00425-3 PMid:15621526
  2. Mohammad, F.K., Al-Baggou, B.K., Naser, A.S., Fadel, M.A. (2014). In vitro inhibition of plasma and brain cholinesterases of growing chicks by chlorpyrifos and dichlorvos. J Appl Anim Res. 42(4): 423-428. https://doi.org/10.1080/09712119.2013.875912
  3. Alatrushi, A.N., Naser, A.S. (2021). The safety profile of the anesthetic effect of alfaxalone and its interaction with xylazine and ketamine in chick’s model. Mac Vet Rev. 44(2): 203-209. https://doi.org/10.2478/macvetrev-2021-0025
  4. Naser, A.S., Albadrany, Y.M. (2021). The neurobehavioral effects of flumazenil in chicks. Iraqi J Vet Sci. 35(4): 783-788. https://doi.org/10.33899/ijvs.2020.128443.1577
  5. Robert, R. (2006). The ‘Miracle’ enzymeTM is serrapeptase, the 2nd gift from Silkworms. Naturally Healthy Publications
  6. Carratu, L., Marangio, E., Cuomo, A., Pesci, A., Sofia, M., Barani, G. (1980). Physico-chemical and rheological research on mucolytic activity of serratiopeptidase in chronic broncho-pneumopathies. Curr Ther Res. 28, 937-951.
  7. Gurung, N., Ray, S., Bose, S., Rai, V. (2013). A broader view: microbial enzymes and their relevance in industries, medicine, and beyond. Biomed Res Int. 2013, 329121. https://doi.org/10.1155/2013/329121 PMid:24106701 PMCid:PMC3784079
  8. Rainsford, K.D. (2007). Anti-inflammatory drugs in the 21st century. Subcell Biochem. 42, 3-27. https://doi.org/10.1007/1-4020-5688-5_1 PMid:17612044
  9. Joshi, K.K., Nerurkar, RP. (2012). Anti-inflammatory effect of the serratiopeptidase--rationale or fashionable: a study in rat paw oedema model induced by the carrageenan. Indian J Physiol Pharmacol. 56(4): 367-374.
  10. Chappi D., M, Suresh, K.V., Patil, M.R., Desai, R., Tauro, D.P., K.N.S. S.B., Parkar, M.I., Babaji, H.V. (2015). Comparison of clinical efficacy of methylprednisolone and ser ratiopeptidase for reduction of postoperative sequelae after lower third molar surgery. J Clin Exp Dent. 7(2): e197-e202. https://doi.org/10.4317/jced.51868 PMid:26155332 PMCid:PMC4483323
  11. Jadav, S.P., Patel, N.H., Shah, T.G., Gajera, M.V., Trivedi, H.R., Shah, B.K. (2010). Comparison of antiinflammatory activity of serratiopeptidase and diclofenac in albino rats. J Pharmacol Pharmacother. 1(2): 116-117. https://doi.org/10.4103/0976-500X.72362 PMid:21350623 PMCid:PMC3043339
  12. Mecikoglu, M., Saygi, B., Yildirim, Y., Karadag-Saygi, E., Ramadan, S.S., Esemenli, T. (2006). The effect of proteolytic enzyme serratiopeptidase in the treatment of experimental implant-related infection. J Bone Joint Surg Am. 88(6): 1208-1214. https://doi.org/10.2106/JBJS.E.00007 PMid:16757752
  13. Buckley, C.D., Gilroy, D.W., Serhan, C.N., Stockinger, B., Tak, P.P. (2013). The resolution of inflammation. Nat Rev Immunol. 13(1): 59-66. https://doi.org/10.1038/nri3362 PMid:23197111
  14. Hosseinzadeh, S.A., Valizadeh, V., Rouhani, M., Mirkazemi, S., Azizi, M., Norouzian, D. (2022). Novel serratiopeptidase exhibits different affinities to the substrates and inhibitors. Chem Biol Drug Des. 100(4): 553-563. https://doi.org/10.1111/cbdd.14105 PMid:35729860
  15. Paul-Murphy, J.R., Brunson, D.B., Miletic, V. (1999). Analgesic effects of butorphanol and buprenorphine in conscious African grey par rots (Psittacus erithacus erithacus and Psittacus erithacus timneh). Am J Vet Res. 60(10): 1218-1221. https://doi.org/10.2460/ajvr.1999.60.10.1218 PMid:10791933
  16. Evrard, H.C., Balthazart, J. (2002). The assessment of nociceptive and non-nociceptive skin sensitivity in the Japanese quail (Coturnix japonica). J Neurosci Methods. 116(2): 135-146. https://doi.org/10.1016/S0165-0270(02)00034-1 PMid:12044663
  17. Naser, A., Albadrany, Y., Shaaban, KA. (2021). Methods of pain assessment in chicks as a model. Egypt J Vet Sci. 52(2): 241-249. https://doi.org/10.21608/ejvs.2021.64605.1219
  18. Naser, A.S., Albadrany, Y., Shaaban, K.A. (2020). Isobolographic analysis of analgesic interactions of silymarin with ketamine in mice. J Hell Vet Med Soc. 71(2): 2171-2178. https://doi.org/10.12681/jhvms.23653
  19. Alberifki, N.M., Naser, A.S. (2023). Flurbiprofen: determination of safety profile, analgesic effect, and interaction with lipoic acid in murine. Iraqi J Vet Sci. 37(2): 447-452. https://doi.org/10.33899/ijvs.2023.136615.2599
  20. Hughes, R.A., Sufka, K.J. (1991). Morphine hyperalgesic effects on the formalin test in domestic fowl (Gallus gallus). Pharmacol Biochem Behav. 38(2): 247-251. https://doi.org/10.1016/0091-3057(91)90273-5 PMid:2057496
  21. Abdul-Ghani, M.R., Naser, A.S. (2022). Bakers’ yeast induced paw edema and fever in chicks for detection of anti-inflammatory effects of alpha-lipoic acid: a new approach. Egypt J Vet Sci. 53(2): 185-191. https://doi.org/10.21608/ejvs.2022.107080.1314
  22. Henry, D.A. (1988). Side-effects of non-steroidal anti-inflammatory drugs. Baillieres Clin Rheumatol. 2(2): 425-454. https://doi.org/10.1016/S0950-3579(88)80021-9 PMid:3066501
  23. El-Ghany, W. (2023). A natural feed additive phytobiotic, pomegranate (Punica granatum L.), and the health status of poultry. Mac Vet Rev. 46(2): 113-128. https://doi.org/10.2478/macvetrev-2023-0022
  24. Yadav, V., Sharma, S., Kumar, A., Singh, S., Ravichandiran, V. (2023). Serratiopeptidase attenuates lipopolysaccharide-induced vascular inflammation by inhibiting the expression of monocyte chemoattractant protein-1. Curr Issues Mol Biol. 45(3): 2201-2212. https://doi.org/10.3390/cimb45030142 PMid:36975512 PMCid:PMC10047379
  25. Mammdoh, J.K., Al-Alsadoon, L.H., Taqa, G.A., Taqa, A.A. (2022). Evaluation of anti-inflammatory effect of topical ser ratiopeptidase in mice. Inflammation. 12(1): 162-166.
  26. Nirale, N.M., Menon, M.D. (2010). Topical formulations of serratiopeptidase: development and pharmacodynamic evaluation. Indian J Pharm Sci. 72(1): 65-71. https://doi.org/10.4103/0250-474X.62246 PMid:20582192 PMCid:PMC2883229
  27. Moriya, N., Shoichi, A., Yoko, H., Fumio, H., Yoshiaki, K. (2003). Intestinal absor ption of serrapeptase and its distribution to the inflammation sites. Japanese Pharmacol Ther. 31(8): 659-666.
  28. Woodley, J.F. (1994). Enzymatic barriers for GI peptide and protein delivery. Crit Rev Ther Drug Carrier Syst. 11(2-3): 61-95.
  29. Moriya, N., Nakata, M., Nakamura, M., Takaoka, M., Iwasa, S, Kato, K. (1994). Intestinal absorption of serrapeptase (TSP) in rats. Biotechnol Appl Biochem. 20(1): 101-108. https://doi.org/10.1111/j.1470-8744.1994.tb00308.x PMid:7917060
  30. Parada, C.A., Tambeli, C.H., Cunha, F. de Q., Ferreira, S.H. (2001). The major role of peripheral release of histamine and 5-hydroxytr yptamine in formalin-induced nociception. Neuroscience. 102(4): 937-944. https://doi.org/10.1016/S0306-4522(00)00523-6 PMid:11182255
  31. Singh, B.M., Negi, G., Bhole, P., Jaiprakash, M. (2012). Pain and inflammation: a review. Int J Pharm Sci Res. 3(12): 4697-4709.
  32. Nair, S.R. (2022). Serratiopeptidase: an integrated view of multifaceted therapeutic enzyme. Biomolecules 12(10): 1468. https://doi.org/10.3390/biom12101468 PMid:36291677 PMCid:PMC9599151
  33. Jadhav, S.B., Shah, N., Rathi, A., Rathi, V., Rathi, A. (2020). Serratiopeptidase: insights into the therapeutic applications. Biotechnol Rep (Amst). 28: e00544. https://doi.org/10.1016/j.btre.2020.e00544 PMid:33134103 PMCid:PMC7585045
  34. El-Radhi, A.S. (2018). Fever in common infectious diseases. Clin Man Fever Child. 85-140. https://doi.org/10.1007/978-3-319-92336-9_5 PMCid:PMC7122655
  35. Ivanov, A.I., Romanovsky, A.A. (2004). Prostaglandin E2 as a mediator of fever: synthesis and catabolism. Front Biosci. 9, 1977-1993. https://doi.org/10.2741/1383 PMid:14977603
  36. Bhagat, S., Agarwal, M., Roy, V. (2013). Serratiopeptidase: a systematic review of the existing evidence. Int J Surg. 11(3): 209-217. https://doi.org/10.1016/j.ijsu.2013.01.010 PMid:23380245
  37. Vaday, G.G., Lider, O. (2000). Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inf lammation. J Leukoc Biol. 67(2): 149-159. https://doi.org/10.1002/jlb.67.2.149 PMid:10670574
  38. Birkedal‐Hansen, H. (1993). Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res. 28(6 Pt 2): 500-510. https://doi.org/10.1111/j.1600-0765.1993.tb02113.x PMid:8263720
  39. Tiwari, M. (2017). The role of serratiopeptidase in the resolution of inflammation. Asian J Pharm Sci. 12(3): 209-215. https://doi.org/10.1016/j.ajps.2017.01.003 PMid:32104332 PMCid:PMC7032259
Language: English
Page range: 115 - 122
Submitted on: Mar 12, 2024
|
Accepted on: Jul 24, 2024
|
Published on: Aug 21, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2024 Ahmed S. Naser, Yasser M. Albadrany, published by Ss. Cyril and Methodius University in Skopje
This work is licensed under the Creative Commons Attribution 4.0 License.